Quality of Life (HRQoL) of AIS Patients Who Require Bracing or Surgery Using SRS-22 Questionnaire
Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 11, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how wearing a brace or having surgery affects the quality of life for teenagers with Adolescent Idiopathic Scoliosis (AIS), a condition where the spine curves unexpectedly. The researchers want to understand what patients think about their treatment, including how it affects their comfort, self-image, and mental health. They will use a questionnaire called the SRS-22 to gather this information from participants, which will help doctors learn how to improve care for these patients over time.
To join the study, you need to be a teenager with AIS who is either required to wear a brace or is scheduled for surgery due to a severe curve in the spine. Participants should be able to read and understand either English or Chinese. If you participate, you can expect to answer questions about your experiences with bracing or surgery, which will help researchers track how these treatments affect your daily life and well-being. It's important to note that the study aims to include patients from a specialized scoliosis clinic, and finding better ways to support those with AIS is a key goal.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • AIS patients who attend the scoliosis clinic at specialized outpatient clinic in Prince of Wales hospital and require wearing brace, or patients who suffer from severe scoliosis and require surgery on their first clinic visit
- • Can read and understand either English or Chinese
- Exclusion Criteria:
- • To observe (i.e. not require to wear brace) after clinic visit
- • Cannot read or understand either English or Chinese
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sha Tin, , Hong Kong
Patients applied
Trial Officials
Alec Lik-Hang Hung, Dr.
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials